STUDY: Next Biotech Plants: New Traits, Crops, Developers and Technologies For Addressing Global Challenges

By Michael Stebbins • October 26, 2016

The following is an excerpt of a study published in Critical Reviews in Biotechnology on the future of plant breeding and plant biotechnology.

Most of the genetically modified (GM) plants currently commercialized encompass a handful of crop species (soybean, corn, cotton and canola) with agronomic characters (traits) directed against some biotic stresses (pest resistance, herbicide tolerance or both) and created by multinational companies. The same crops with agronomic traits already on the market today will continue to be commercialized, but there will be also a wider range of species with combined traits.

The timeframe anticipated for market release of the next biotech plants will not only depend on science progress in research and development (R&D) in laboratories and fields, but also primarily on how demanding regulatory requirements are in countries where marketing approvals are pending. Regulatory constraints, including environmental and health impact assessments, have increased significantly in the past decades, delaying approvals and increasing their costs. This has sometimes discouraged public research entities and small and medium size plant breeding companies from using biotechnology and given preference to other technologies, not as stringently regulated.

Nevertheless, R&D programs are flourishing in developing countries, boosted by the necessity to meet the global challenges that are food security of a booming world population while mitigating climate change impacts. Biotechnology is an instrument at the service of these imperatives and a wide variety of plants are currently tested for their high yield despite biotic and abiotic stresses. Many plants with higher water or nitrogen use efficiency, tolerant to cold, salinity or water submergence are being developed.

Food security is not only a question of quantity but also of quality of agricultural and food products, to be available and accessible for the ones who need it the most. Many biotech plants (especially staple food) are therefore being developed with nutritional traits, such as biofortification in vitamins and metals. The main international seed companies continue to be the largest investors in plant biotechnology R&D, and often collaborate in the developing world with public institutions, private entities and philanthropic organizations. These partnerships are particularly present in Africa.

In developed countries, plant biotechnology is also used for non-food purposes, such as the pharmaceutical, biofuel, starch, paper and textile industries. For example, plants are modified to specifically produce molecules with therapeutic uses, or with an improved biomass conversion efficiency, or producing larger volumes of feedstocks for biofuels. 

To read the entire study, please visit PubMed.gov. 

Posted on July 30, 2018
Genetic engineering (GE) touches on the routine life of billions of people (but not everyone). Food, clothes, and medicine are commonly made with the help of genetically engineered organisms. Certain medicines, like insulin, could only be mass-produced this way. Fiber for clothes is made less expensive thanks to GE cotton plants. You also PROBABLY sometimes eat plants with a few engineered genes, depending on where you live. But genetic engineering isn’t just for making new or better... Read More
Answer:
Posted on March 9, 2018
Thanks for the question. I believe you are asking about how corn hybrids are produced. For starters, corn plants have both female (silks and cobs) and male parts (tassels). This means that in a field of corn, any plant can fertilize any other plant (hybrid), including itself (inbred).   Breeders create new hybrids by cross pollinating genetics of a specific male inbred (plants with uniform performance) with a specific female inbred. This is done by planting one row of the male... Read More
Answer:
Posted on May 4, 2018
There would be more public seed development if genome editing technologies like CRISPR are not regulated as GMOs. Single point mutations are an extension of the undirected mutation breeding that is commonly used now. Having genome editing regulated like conventional plant breeding would allow university plant breeders to use the technology to develop new varieties without the stigmatism of them being GMOs. As for would it allow for more start-up seed companies, this is more doubtful. It is... Read More
STUDY: Community composition and functions of endophytic bacteria of Bt maize
STUDY: An overview of the last 10 years of genetically engineered crop safety research